Stabilization of chloroquine resistance in vivo of Plasmodium falciparum in Edea, south Cameroon

Author(s):  
Bert Mulder ◽  
Pascal Ringwald ◽  
Theo Arens ◽  
Francis Louis
Acta Tropica ◽  
2005 ◽  
Vol 95 (3) ◽  
pp. 219-225 ◽  
Author(s):  
Pembe Issamou Mayengue ◽  
Mathieu Ndounga ◽  
Matondo Maya Davy ◽  
Ntsonde Tandou ◽  
Francine Ntoumi

2006 ◽  
Vol 100 (1) ◽  
pp. 141-148 ◽  
Author(s):  
C. T. Happi ◽  
G. O. Gbotosho ◽  
O. A. Folarin ◽  
A. Sowunmi ◽  
O. M. Bolaji ◽  
...  

1999 ◽  
Vol 61 (2) ◽  
pp. 240-244 ◽  
Author(s):  
E Gómez-Saladín ◽  
A I Susanti ◽  
W R Taylor ◽  
D J Fryauff ◽  
B Subianto ◽  
...  

Parasitology ◽  
1999 ◽  
Vol 119 (4) ◽  
pp. 343-348 ◽  
Author(s):  
I. S. ADAGU ◽  
D. C. WARHURST

This study examines polymorphisms in 2 genes (pfmdr1 and cg2), which have been associated with resistance to chloroquine in Plasmodium falciparum, to determine their value as predictors of resistance status. Among field samples from children in Zaria, northern Nigeria, the Tyr-86 polymorphism in pfmdr1 and Ala-281 and the Dd2κ repeat of cg2, were significantly associated. In 8 samples classified resistant by the micro-in vitro test, or, where this failed, by in vivo trial, 7 showed the cg2 Dd2 type κ repeat, and 6 of these had both the Ala-281 allele and the pfmdr1 Tyr-86 allele. In 26 chloroquine-sensitive samples, none had this combination of 3 polymorphisms (P = 0·00002). This indicates 75% sensitivity and 100% specificity in detection of resistance and shows a positive predictive value for resistant infections of 100%. The negative predictive value, because of sensitivity less than 100%, would depend on the prevalence of resistance. Where prevalence of resistance is approx. 21% as in Zaria, the negative predictive value would be 94%, while in Gabon, with a prevalence of ca 73% it would be 60%. The use of (cg2: Ala-281, Dd2κ. pfmdr1: Tyr-86) genotype detection as a predictive epidemiological tool to examine the distribution of chloroquine-resistance in parts of Africa is therefore possible. The sensitivity of detection of resistant strains still requires improvement.


2003 ◽  
Vol 3 (4) ◽  
pp. 287-292 ◽  
Author(s):  
Halidou Tinto ◽  
Jean Bosco Ouédraogo ◽  
Annette Erhart ◽  
Chantal Van Overmeir ◽  
Jean-Claude Dujardin ◽  
...  

1997 ◽  
Vol 27 (3) ◽  
pp. 146-149 ◽  
Author(s):  
O E Antia-Obong ◽  
A A A Alaribe ◽  
M U Young ◽  
A Bassy ◽  
B V Etim

Sixty-nine children aged between 6 and 60 months with parasitologically proven Plasmodium falciparum malaria were treated with chloroquine (2.5 mg/kg) in the Children's Emergency Room of the University of Calabar Teaching Hospital (UCTH) in 1993. Thirty subjects (mean age 27.8 months) and 39 (mean age 29.5 months) received chloroquine phosphate suppository (Pharma Deko) and chloroquine sulphate syrup (May & Baker), respectively. The World Health Organization (WHO) 14-day in vivo field test was used in evaluating the response to treatment. In both treatment groups the responses were similar. Overall, parasitological cure occurred in 24 subjects (34.8%) and in the remaining 45 subjects (65.2%) treatment failed (chloroquine resistance). This level of chloroquine resistant Plasmodium falciparum (CRPF) is higher than 53.6% reported in this centre in 1989. Furthermore, in the present study the proportion of RII (46.4%) is significantly higher than 21.4% ( P < 0.02) obtained in 1989. Our findings show a worsening of CRPF in Calabar with RII being the main contributor. This observation indicates the need for continued surveillance of the response of P. falciparum to chloroquine and alternative antimalarials as a means of evolving an effective treatment policy for malaria.


Sign in / Sign up

Export Citation Format

Share Document